Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Carlisle Companies Inc (CSL)
Carlisle Companies Inc (CSL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,651,198
  • Shares Outstanding, K 48,683
  • Annual Sales, $ 6,592 M
  • Annual Income, $ 921,800 K
  • 60-Month Beta 0.88
  • Price/Sales 2.03
  • Price/Cash Flow 10.83
  • Price/Book 4.55
Trade CSL with:

Options Overview Details

View History
  • Implied Volatility 25.68% ( +0.14%)
  • Historical Volatility 27.22%
  • IV Percentile 36%
  • IV Rank 28.30%
  • IV High 39.25% on 01/20/23
  • IV Low 20.33% on 07/28/23
  • Put/Call Vol Ratio 0.16
  • Today's Volume 22
  • Volume Avg (30-Day) 18
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 2,680
  • Open Int (30-Day) 2,806

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 3.38
  • Number of Estimates 3
  • High Estimate 3.47
  • Low Estimate 3.33
  • Prior Year 3.92
  • Growth Rate Est. (year over year) -13.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
259.74 +10.19%
on 11/02/23
288.31 -0.73%
on 12/01/23
+30.32 (+11.85%)
since 11/01/23
3-Month
235.79 +21.38%
on 10/25/23
288.31 -0.73%
on 12/01/23
+17.62 (+6.56%)
since 09/01/23
52-Week
203.65 +40.54%
on 04/05/23
289.12 -1.01%
on 08/10/23
+24.11 (+9.20%)
since 12/01/22

Most Recent Stories

More News
Health Canada Authorizes CSL's HEMGENIX® (etranacogene dezaparvovec) as First Gene Therapy for Hemophilia B

/CNW/ -- Global biotechnology leader CSL (ASX: CSL) today announced that Health Canada has authorized HEMGENIX® (etranacogene dezaparvovec), the first and only...

CSL.AX : 262.860 (+0.24%)
CSL : 286.21 (+2.07%)
New Data Presented at IDWeek 2023 Demonstrates Public Health Benefit and Cost Savings Associated with Cell-Based and Adjuvanted Influenza Vaccines

Data evaluating the impact of cell-based quadrivalent influenza vaccines suggests an additional 31%–39% of influenza cases may have been prevented among...

CSL : 286.21 (+2.07%)
CSL Seqirus Presents Real-World Evidence at ESWI Demonstrating the Impact of Influenza Vaccination Campaigns to Help Protect People and Healthcare Systems

Results from a retrospective cohort study from 2015 to 2020 demonstrated a notable rise with increasing age in pneumonia-related medical encounters following...

CSL : 286.21 (+2.07%)
CSL Seqirus Announces Third U.S. Government Award in Relation to Influenza A(H5N8) Candidate Vaccine

/PRNewswire/ -- CSL Seqirus, a business of CSL (ASX: CSL), was selected by the Biomedical Advanced Research and Development Authority (BARDA), part of the...

CSL : 286.21 (+2.07%)
CSL Appoints Jeffrey Ball as First Chief Sustainability Officer

/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) (USOTC: CSLLY) announced today that Jeffrey Ball, an established global leader across multiple...

CSL : 286.21 (+2.07%)
CSLLY : 88.2600 (+1.74%)
CSL Seqirus Begins Shipping Portfolio of Innovative Influenza Vaccines for the 2023/24 U.S. Season

CSL Seqirus is the only influenza vaccine manufacturer that offers differentiated vaccine options for individuals six months of age and older. Since the...

CSL : 286.21 (+2.07%)
4 Industrial Stocks That Are Screaming Buys in June

These vital manufacturers could produce stellar returns.

CAT : 256.76 (+2.41%)
MMM : 99.85 (+0.79%)
CSL : 286.21 (+2.07%)
DOV : 143.21 (+1.45%)
Carlisle (CSL) Q1 Earnings Miss Estimates, Sales Decline Y/Y

Carlisle's (CSL) first-quarter 2023 earnings decline 39.7% on a year-over-year basis due to lower sales.

PH : 440.16 (+1.61%)
IR : 72.24 (+1.13%)
CSL : 286.21 (+2.07%)
ALLE : 108.69 (+2.45%)
Carlisle Companies Declares Regular Quarterly Dividend

Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.75 per share, payable on June 1, 2023, to shareholders of record at the close of business on May 17, 2023.

CSL : 286.21 (+2.07%)
Carlisle Companies Elects C. David Myers to its Board of Directors

Carlisle Companies Incorporated (NYSE:CSL) announced today that C. David Myers has been elected to its Board of Directors effective immediately.

CSL : 286.21 (+2.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Carlisle Companies Incorporated is a diversified, global portfolio of niche brands and businesses with highly engineered and high margin products. It engages in the design, manufacture and sale of a wide range of roofing and waterproofing products, engineered products and finishing equipment. The company...

See More

Key Turning Points

3rd Resistance Point 300.39
2nd Resistance Point 294.35
1st Resistance Point 290.28
Last Price 286.21
1st Support Level 280.17
2nd Support Level 274.13
3rd Support Level 270.06

See More

52-Week High 289.12
Last Price 286.21
Fibonacci 61.8% 256.47
Fibonacci 50% 246.39
Fibonacci 38.2% 236.30
52-Week Low 203.65

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar